Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The cysteine binding sites of cisplatin in HeLa cells

ABSTRACT: The binding proteins of cisplatin in hela cells was identified by LC-MS/MS

ORGANISM(S): Homo Sapiens

SUBMITTER: Zhifeng Du

PROVIDER: PXD048787 | iProX | Tue Jan 23 00:00:00 GMT 2024

REPOSITORIES: iProX

ACCESS DATA

Json Xml

Similar Datasets

Gene Expression in Cisplatin Resistance HeLa Cells

Project description:Cisplatin resistance is a problem in cancer treatment. Using DNA microarray, we detected differentially expressed genes in cisplatin-resistant cervix carcinoma HeLa cells compared to parental cells. Three cisplatin resistant cell lines were established by stepwise increasing cisplatin concentration. RNA from these resistant lines and its parental HeLa cells were labeled with Cy5 and Cy3. Equal amount of RNA from resistant cell line and HeLa were mixed and were hybridized to cDNA array. Signals were scanned and analyzed to find out the candidate genes involved in cisplatin resistant mechanism.

2010-05-06 | E-GEOD-15120 | biostudies-arrayexpress

Gene Expression in Cisplatin Resistance HeLa Cells

2010-03-05 | GSE15120 | GEO

MYC binding sites in HeLa cells

Project description:MYC binding sites determined in HeLa cells using ChIP-chip Keywords: ChIP-chip

2006-03-09 | GSE4354 | GEO

MYC binding sites in HeLa cells

Project description:MYC binding sites determined in HeLa cells using ChIP-chip ChIP-chip

2010-07-01 | E-GEOD-4354 | biostudies-arrayexpress

Gene expression data from parental HeLa and Dickkopf-1 (Dkk1) knockout HeLa cells after Cisplatin treatment

Project description:Infection with oncogenic human papillomavirus (HPV) is a major cause for the development of cervical cancer, which is mainly driven by the expression of the HPV E6 and E7 oncoproteins. We uncovered that the concentration levels of the putative tumor suppressor Dickkopf-1 (Dkk1) are restricted in cervical cancer cells by HPV E6 expression due to the E6-mediated proteolytic degradation of p53, which is a transcriptional regulator of Dkk1. Moreover, we found that Dkk1 is critically involved in the pro-apoptotic Cisplatin response of these cells, as Dkk1 repression was associated with an increased resistance towards the chemotherapeutic compound. This could be of high relevance for cervical cancer treatments, which usually involve Cisplatin for standard care. Although Dkk1 is a major antagonist of the canonical Wnt signaling, the differential response towards Cisplatin observed in Dkk1-depleted cells was not associated to an activation of this pathway. To elucidate alternative underlying mechanisms, we performed Affymetrix Gene Expression analyses comparing the transcriptome of Cisplatin-treated parental HeLa to CRISPR/Cas9-generated Dkk1 knockout (KO) HeLa cells. These revealed that Dkk1 depletion is linked to an impairment of the pro-apoptotic JNK/AP-1 pathway in cervical cancer cells, suggesting that Dkk1 drives Cisplatin-mediated apoptosis via activation of this signaling hub.

2022-08-16 | GSE200748 | GEO

Identifying LINC00899 binding sites in HeLa cells with CHART-seq

Project description:Identifying LINC00899 binding sites in HeLa cells with CHART-seq

| PRJEB29987 | ENA

Death Receptor 5 Antisense Long Noncoding RNA and Cisplatin Modulate Macromolecular and Metabolic Changes in HeLa Cells

Project description:We have performed a transcriptomics study in which we first apply cisplatin to HeLa cells. Total RNA was isolated from control as well as treated cells and apoptosis was confirmed by Annexin V and 7AAD staining in flow cytometry. Total RNAs were subjected to deep-sequencing to identify differentially expressed mRNAs. We then took advantage of bioinformatic tools to identify which pathways are affected by Cisplatin treatment

2024-01-17 | GSE193447 | GEO

ENO1's RNA-binding sites in Human HeLa cells using eCLIP

Project description:ENO1's RNA-binding sites in Human HeLa cells using eCLIP

| PRJEB38054 | ENA

Gene expression data from parental HeLa and Dickkopf-1 (Dkk1) knockout HeLa cells after Cisplatin treatment

Project description:Gene expression data from parental HeLa and Dickkopf-1 (Dkk1) knockout HeLa cells after Cisplatin treatment

| PRJNA826477 | ENA

The identification of binding site of cisplatin on serum proteins

Project description:The binding proteins of cisplatin in serum was identified by LC-IM-MS/MS.

2021-04-21 | PXD025502 |